BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

38 related articles for article (PubMed ID: 21753764)

  • 1. Mechanisms of fibroblast cell therapy for dystrophic epidermolysis bullosa: high stability of collagen VII favors long-term skin integrity.
    Kern JS; Loeckermann S; Fritsch A; Hausser I; Roth W; Magin TM; Mack C; Müller ML; Paul O; Ruther P; Bruckner-Tuderman L
    Mol Ther; 2009 Sep; 17(9):1605-15. PubMed ID: 19568221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammation-mediated fibroblast activation and immune dysregulation in collagen VII-deficient skin.
    Anderson-Crannage M; Ascensión AM; Ibanez-Solé O; Zhu H; Schaefer E; Ottomanelli D; Hochberg B; Pan J; Luo W; Tian M; Chu Y; Cairo MS; Izeta A; Liao Y
    Front Immunol; 2023; 14():1211505. PubMed ID: 37809094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Raising Awareness Among Healthcare Providers about Epidermolysis Bullosa and Advancing Toward a Cure.
    Tabor A; Pergolizzi JV; Marti G; Harmon J; Cohen B; Lequang JA
    J Clin Aesthet Dermatol; 2017 May; 10(5):36-48. PubMed ID: 28670357
    [No Abstract]   [Full Text] [Related]  

  • 4. Preconditioning of mesenchymal stem cells for improved transplantation efficacy in recessive dystrophic epidermolysis bullosa.
    Perdoni C; McGrath JA; Tolar J
    Stem Cell Res Ther; 2014 Nov; 5(6):121. PubMed ID: 25376815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Somatic correction of junctional epidermolysis bullosa by a highly recombinogenic AAV variant.
    Melo SP; Lisowski L; Bashkirova E; Zhen HH; Chu K; Keene DR; Marinkovich MP; Kay MA; Oro AE
    Mol Ther; 2014 Apr; 22(4):725-33. PubMed ID: 24390279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allogeneic blood and bone marrow cells for the treatment of severe epidermolysis bullosa: repair of the extracellular matrix.
    Tolar J; Wagner JE
    Lancet; 2013 Oct; 382(9899):1214-23. PubMed ID: 24095195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular therapeutics for heritable skin diseases.
    Uitto J
    J Invest Dermatol; 2012 Nov; 132(E1):E29-34. PubMed ID: 23154630
    [No Abstract]   [Full Text] [Related]  

  • 8. Novel molecular therapies for heritable skin disorders.
    Uitto J; Christiano AM; McLean WH; McGrath JA
    J Invest Dermatol; 2012 Mar; 132(3 Pt 2):820-8. PubMed ID: 22158553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone marrow stem cell therapy for recessive dystrophic epidermolysis bullosa.
    Kiuru M; Itoh M; Cairo MS; Christiano AM
    Dermatol Clin; 2010 Apr; 28(2):371-82, xii-xiii. PubMed ID: 20447506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell-based therapy for RDEB: how does it work?
    Uitto J
    J Invest Dermatol; 2011 Aug; 131(8):1597-9. PubMed ID: 21753764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HB-EGF induces COL7A1 expression in keratinocytes and fibroblasts: possible mechanism underlying allogeneic fibroblast therapy in recessive dystrophic epidermolysis Bullosa.
    Nagy N; Almaani N; Tanaka A; Lai-Cheong JE; Techanukul T; Mellerio JE; McGrath JA
    J Invest Dermatol; 2011 Aug; 131(8):1771-4. PubMed ID: 21471992
    [No Abstract]   [Full Text] [Related]  

  • 12. Potential of fibroblast cell therapy for recessive dystrophic epidermolysis bullosa.
    Wong T; Gammon L; Liu L; Mellerio JE; Dopping-Hepenstal PJ; Pacy J; Elia G; Jeffery R; Leigh IM; Navsaria H; McGrath JA
    J Invest Dermatol; 2008 Sep; 128(9):2179-89. PubMed ID: 18385758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibroblast-based cell therapy strategy for recessive dystrophic epidermolysis bullosa.
    Yan WF; Murrell DF
    Dermatol Clin; 2010 Apr; 28(2):367-70, xii. PubMed ID: 20447505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene-Corrected Fibroblast Therapy for Recessive Dystrophic Epidermolysis Bullosa using a Self-Inactivating COL7A1 Retroviral Vector.
    Jacków J; Titeux M; Portier S; Charbonnier S; Ganier C; Gaucher S; Hovnanian A
    J Invest Dermatol; 2016 Jul; 136(7):1346-1354. PubMed ID: 26994967
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.